Lv4
596 积分 2025-01-21 加入
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
1个月前
已完结
Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus
1个月前
已完结
Comparative analysis of hepatectomy for HCC with PVTT: Insights from a 30-year single-center experience
1个月前
已完结
Portal vein tumor thrombosis has a direct impact on liver function
1个月前
已完结
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison
2个月前
已完结
Application of hepatic artery interventional therapies in the conversion treatment of unresectable hepatocellular carcinoma: A systematic review and meta-analysis
2个月前
已完结
Recent advances in metabolism and toxicity of tyrosine kinase inhibitors
2个月前
已完结
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials
2个月前
已完结
Application of hepatic artery interventional therapies in the conversion treatment of unresectable hepatocellular carcinoma: A systematic review and meta-analysis
2个月前
已完结
Immunotherapy for hepatocellular carcinoma
2个月前
已完结
皖公网安备34019202002308
